These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6260094)

  • 1. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
    Motulsky HJ; Shattil SJ; Insel PA
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1562-70. PubMed ID: 6260094
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A
    Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different sedimentation properties of agonist- and antagonist-labelled platelet alpha 2 adrenergic receptors.
    Michel T; Hoffman BB; Lefkowitz RJ; Caron MG
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1131-6. PubMed ID: 6268079
    [No Abstract]   [Full Text] [Related]  

  • 4. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
    Limbird LE; MacMillan ST; Smith SK
    Adv Cyclic Nucleotide Res; 1981; 14():189-98. PubMed ID: 6116384
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone-sensitive adenylate cyclase. Delineation of a trypsin-sensitive site in the pathway of receptor-mediated inhibition.
    Stiles GL; Lefkowitz RJ
    J Biol Chem; 1982 Jun; 257(11):6287-91. PubMed ID: 6281265
    [No Abstract]   [Full Text] [Related]  

  • 6. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ; Insel PA
    Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES; Addonizio VP; Shattil SJ
    Am J Physiol; 1982 Jan; 242(1):H19-23. PubMed ID: 6277203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets.
    Ferry N; Adnot S; Borsodi A; Lacombe ML; Guellaën G; Hanoune J
    Biochem Biophys Res Commun; 1982 Sep; 108(2):708-14. PubMed ID: 6293500
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.
    Boon NA; Elliott JM; Grahame-Smith DG; St John-Green T; Stump K
    J Auton Pharmacol; 1983 Jun; 3(2):89-95. PubMed ID: 6309852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    Karliner JS; Motulsky HJ; Insel PA
    Mol Pharmacol; 1982 Jan; 21(1):36-43. PubMed ID: 6127620
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA; Johnston CI
    Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE; Stump DC
    Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
    García-Sevilla JA; Hollingsworth PJ; Smnith CB
    Eur J Pharmacol; 1981 Sep; 74(4):329-41. PubMed ID: 6271559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GTP regulates binding of agonists to alpha 2-adrenergic receptors in human platelets.
    Brodde OE; Hardung A; Ebel H; Bock KD
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):193-207. PubMed ID: 6127987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased central alpha-2 adrenergic receptors measured with [3H] yohimbine in the presence of sodium ion and guanylnucleotides.
    Woodcock EA; Murley B
    Biochem Biophys Res Commun; 1982 Mar; 105(1):252-8. PubMed ID: 6284145
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for high and low affinity alpha 2-receptors. Comparison of [3H]norepinephrine and [3H]phentolamine binding to human platelet membranes.
    Lynch CJ; Steer ML
    J Biol Chem; 1981 Apr; 256(7):3298-303. PubMed ID: 6259160
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
    Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    Mooney JJ; Horne WC; Handin RI; Schildkraut JJ; Alexander RW
    Mol Pharmacol; 1982 May; 21(3):600-8. PubMed ID: 6287197
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranes.
    Michel T; Lefkowitz RJ
    J Biol Chem; 1982 Nov; 257(22):13557-63. PubMed ID: 6292195
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
    Lefkowitz RJ; De Lean A; Hoffman BB; Stadel JM; Kent R; Michel T; Limbird L
    Adv Cyclic Nucleotide Res; 1981; 14():145-61. PubMed ID: 6269377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.